Chymase cleavage of stem cell factor yields a bioactive, soluble product.

Stem cell factor (SCF) is produced by stromal cells as a membrane-bound molecule, which may be proteolytically cleaved at a site close to the membrane to produce a soluble bioactive form. The proteases producing this cleavage are unknown. In this study, we demonstrate that human mast cell chymase, a chymotrypsin-like protease, cleaves SCF at a novel site. Cleavage is at the peptide bond between Phe-158 and Met-159, which are encoded by exon 6 of the SCF gene. This cleavage results in a soluble bioactive product that is 7 amino acids shorter at the C terminus than previously identified soluble SCF. This research shows the identification of a physiologically relevant enzyme that specifically cleaves SCF. Because mast cells express the KIT protein, the receptor for SCF, and respond to SCF by proliferation and degranulation, this observation identifies a possible feedback loop in which chymase released from mast cell secretory granules may solubilize SCF bound to the membrane of surrounding stromal cells. The liberated soluble SCF may in turn stimulate mast cell proliferation and differentiated functions; this loop could contribute to abnormal accumulations of mast cells in the skin and hyperpigmentation at sites of chronic cutaneous inflammation.

[1]  T. Boone,et al.  Epitope mapping and immunoneutralization of recombinant human stem-cell factor. , 1996, European journal of biochemistry.

[2]  G. Demetri,et al.  Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo , 1996, The Journal of experimental medicine.

[3]  Laura H. Tang,et al.  Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm , 1996, Nature Genetics.

[4]  Y. Suzuki,et al.  Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Grichnik,et al.  Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patients. , 1995, Journal of the American Academy of Dermatology.

[6]  G. Caughey.  Mast Cell Proteases in Immunology and Biology , 1995 .

[7]  T. Duffy,et al.  The mast cell and mast cell disease. , 1995, Journal of the American Academy of Dermatology.

[8]  B. Wehrle-Haller,et al.  Soluble and cell-bound forms of steel factor activity play distinct roles in melanocyte precursor dispersal and survival on the lateral neural crest migration pathway. , 1995, Development.

[9]  D. Williams,et al.  Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. , 1995, Blood.

[10]  D. Whitaker‐Menezes,et al.  Human dermal endothelial cells express membrane-associated mast cell growth factor. , 1995, The Journal of investigative dermatology.

[11]  D. Metcalfe,et al.  Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population , 1994 .

[12]  D. Williams,et al.  Identification and mutation of primary and secondary proteolytic cleavage sites in murine stem cell factor cDNA yields biologically active, cell-associated protein. , 1994, The Journal of biological chemistry.

[13]  D. Metcalfe,et al.  Stem cell factor induces mast cell adhesion to fibronectin. , 1994, Journal of immunology.

[14]  R. Anthony,et al.  Porcine stem cell factor/c-kit ligand: its molecular cloning and localization within the uterus. , 1994, Biology of reproduction.

[15]  B. Cooperman,et al.  Reaction of human chymase with reactive site variants of alpha 1-antichymotrypsin. Modulation of inhibitor versus substrate properties. , 1993, The Journal of biological chemistry.

[16]  D. Metcalfe,et al.  IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. , 1993, Journal of immunology.

[17]  Z. Jian-hua,et al.  Sequence of a cDNA encoding chicken stem cell factor. , 1993 .

[18]  D. Williams,et al.  Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. , 1993, The New England journal of medicine.

[19]  R. Halaban,et al.  Pigmentation and Proliferation of Human Melanocytes and the Effects of Melanocyte‐Stimulating Hormone and Ultraviolet B Light a , 1993, Annals of the New York Academy of Sciences.

[20]  P. Valent,et al.  Specific activation of human mast cells by the ligand for c-kit: comparison between lung, uterus and heart mast cells. , 1993, International archives of allergy and immunology.

[21]  J. Massagué,et al.  Membrane-anchored growth factors. , 1993, Annual review of biochemistry.

[22]  S. Galli,et al.  Reversible expansion of primate mast cell populations in vivo by stem cell factor. , 1993, The Journal of clinical investigation.

[23]  S. Suggs,et al.  Canine stem cell factor (c-kit ligand) supports the survival of hematopoietic progenitors in long-term canine marrow culture. , 1992, Experimental hematology.

[24]  D. Chang,et al.  Post-translational processing of membrane-associated recombinant human stem cell factor expressed in Chinese hamster ovary cells. , 1992, Archives of biochemistry and biophysics.

[25]  D. Williams,et al.  Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Galli,et al.  The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. , 1992, Journal of immunology.

[27]  J. Wypych,et al.  Purification and characterization of soluble forms of human and rat stem cell factor recombinantly expressed by Escherichia coli and by Chinese hamster ovary cells. , 1992, Archives of biochemistry and biophysics.

[28]  I. Bernstein,et al.  Isolation and characterization of a monoclonal antibody that recognizes the human c-kit receptor. , 1992, Blood.

[29]  M. Tsai,et al.  The rat c-kit ligand, stem cell factor, induces c-kit receptor- dependent mouse mast cell activation in vivo. Evidence that signaling through the c-kit receptor can induce expression of cellular function , 1992, Journal of Experimental Medicine.

[30]  M. Tsai,et al.  Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Tsai,et al.  The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype , 1991, The Journal of experimental medicine.

[32]  J. Wypych,et al.  Amino acid sequence and post-translational modification of stem cell factor isolated from buffalo rat liver cell-conditioned medium. , 1991, The Journal of biological chemistry.

[33]  K. Misono,et al.  Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. , 1990, The Journal of biological chemistry.

[34]  P. Leder,et al.  The hematopoietic growth factor KL is encoded by the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus , 1990, Cell.

[35]  C. March,et al.  Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms , 1990, Cell.

[36]  David A. Williams,et al.  Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor , 1990, Cell.

[37]  K. Zsebo,et al.  Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium , 1990, Cell.

[38]  P. Leder,et al.  The kit ligand: A cell surface molecule altered in steel mutant fibroblasts , 1990, Cell.

[39]  K. Zsebo,et al.  Primary structure and functional expression of rat and human stem cell factor DNAs , 1990, Cell.

[40]  R. Lavker,et al.  Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[41]  R. Fetter,et al.  Purification and identification of two serine class proteinases from dog mast biochemically and immunologically similar to human proteinases tryptase and chymase. , 1988, Archives of biochemistry and biophysics.

[42]  L. Schwartz,et al.  Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. , 1987, Journal of immunology.

[43]  R. Lavker,et al.  Identification of a chymotrypsin-like proteinase in human mast cells. , 1986, Journal of immunology.

[44]  T. Tanaka,et al.  Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide chloromethyl ketone and sulfonyl fluoride inhibitors. , 1985, Biochemistry.

[45]  L. Schwartz,et al.  Angiotensin I conversion by human and rat chymotryptic proteinases. , 1984, The Journal of investigative dermatology.

[46]  G. Lazarus,et al.  Human skin chymotryptic proteinase. Isolation and relation to cathepsin g and rat mast cell proteinase I. , 1983, The Journal of biological chemistry.

[47]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.